MENU
TRLV
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
TRLV stock forecast, quote, news & analysis
A.I.Advisor
published price charts
Intraday
A.I.Advisor
a Summary for TRLV with price predictions
May 22, 2026
TRLV in upward trend: price may jump up because it broke its lower Bollinger Band on May 15, 2026
TRLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 41 cases where TRLV's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
A.I.Advisor
published Highlights
Notable companies
The most notable companies in this group are Teva Pharmaceutical Industries Limited (NYSE:TEVA), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Bausch Health Companies (NYSE:BHC), Tilray Brands Inc. (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).
Industry description
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Market Cap
The average market capitalization across the Pharmaceuticals: Generic Industry is 4.04B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.
High and low price notable news
The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 3%. For the same Industry, the average monthly price growth was 23%, and the average quarterly price growth was 10%. GELS experienced the highest price growth at 101%, while RDHL experienced the biggest fall at -21%.
Volume
The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was 119%. For the same stocks of the Industry, the average monthly volume growth was 41% and the average quarterly volume growth was -57%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 52
P/E Growth Rating: 66
Price Growth Rating: 59
SMR Rating: 87
Profit Risk Rating: 84
Seasonality Score: 12 (-100 ... +100)
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I. Advisor
published General Information